Borreliosis diagnostics is often based on the clinical appearance together with anamnesis and the evidence of specific antibodies.

Fundamentally, a positive Borrelia antibody test is separately no indicator for a therapy or reflects the clinical manifestations. In this case, detection of Borrelia-specific effector T-cells can provide further diagnostic assistance.

The AID LymeSpot Kit detects and measures the Interferon-y expression of Borrelia-specific effector T-cells

Categories: Stem Cells therapy


contract research organization

stem cell therapy